March 18, 2022
Marcy l’Etoile, France – bioMérieux, a world leader in the field of in vitro diagnostics, announces that VITEK® MS PRIME, its new MALDI-TOF1 mass spectrometry identification system, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). This next generation system for routine microbial identification in minutes is now commercially available in countries [...]
Australian National Phenome Center Breaks New Ground in Long COVID Research
March 18, 2022
PERTH, Australia – Bruker today announces another significant milestone in its collaborator’s efforts to map the long-term risk of disease related to SARS-CoV-2 infection using nuclear magnetic resonance (NMR) spectroscopy. Researchers from the Australian National Phenome Center (ANPC) have recently published results from a study that demonstrate the use of NMR to measure the increased cardiovascular risk [...]
Pharmaron Adopts ACD/Labs NMR Software for Structure Elucidation
March 18, 2022
Toronto, CANADA — ACD/Labs, an informatics company that develops and commercializes software in support of R&D, today announced that Pharmaron Inc. has chosen to equip their scientists with ACD/Labs' industry leading NMR processing and interpretation software. Among the applications adopted by Pharmaron is ACD/Structure Elucidator Suite, bringing computer assisted structure elucidation into their analytical services [...]
March 17, 2022
Fluidigm Board of Directors Unanimously Recommends Stockholders Vote “FOR” ALL Proposals TODAY SOUTH SAN FRANCISCO, Calif. -- Fluidigm Corporation (NASDAQ:FLDM), today announced that leading independent proxy advisory firms Institutional Shareholder Services (“ISS”) and Glass, Lewis & Co. (“Glass Lewis”) have recommended that Fluidigm stockholders vote “FOR” ALL proposals related to the previously announced strategic capital [...]
Nanalysis Scientific Corp. Announces $4,985,000 Funding Contribution from the Canadian Government
March 17, 2022
CALGARY, AB - Nanalysis Scientific Corp. (TSXV:NSCI, OTCQX:NSCIF, FRA:1N1) ("Nanalysis" or the "Company") announces that the Company has received repayable funding of $4,985,000 to expand manufacturing operations and global markets for nuclear magnetic resonance products from the government of Canada. "We are very thankful for the support from the Canadian government," said Sean Krakiwsky, founder and Chief Executive [...]
Mettler-Toledo International Inc. Provides Statement Related to Ukraine
March 17, 2022
Columbus, OH - We are deeply concerned and saddened by the continued developments in Ukraine. Since the beginning of the invasion, we have suspended all shipments to Russia. The company does not have manufacturing in Russia. We also remain in constant contact with our employees in Ukraine and have provided financial assistance and supplies as [...]
March 17, 2022
ST. PAUL, Minn. -- Scientific Bioprocessing, Inc. (SBI) and BioMADE announced today that up to 23 community and technical colleges will receive free state-of-the-art bioprocessing equipment through the SBI Digitally Simplified Bioprocessing Fellowship. The equipment – valued at up to $368,000 – will bring real-time solutions to biomass monitoring and bioprocessing technology training resources to [...]
March 17, 2022
Eschwege, Germany - The Molecular Biology group of MP Biomedicals having more than twenty years of experience in the research and development of sample preparation and nucleic acid purification solutions is pleased to announce the release of two new kits designed for the isolation of total RNA from animal and plant tissues, cultured cells and [...]
March 17, 2022
Eschwege, Germany: - The Molecular Biology group of MP Biomedicals having more than twenty years of experience in the research and development of sample preparation and nucleic acid purification solutions is pleased to announce the release of two new kits designed for the isolation of total RNA from animal and plant tissues, cultured cells and bacteria [...]
March 17, 2022
PRINCETON, N.J. -- NJ Bio is procuring an 800 MHz NMR spectrometer with a cryogenic probe from JEOL. As part of this collaboration, NJ Bio will contribute its expertise in antibody drug conjugates, oligonucleotide conjugates, and other chemistries to develop platform solutions for its drug discovery clients - in particular, a platform for using NMR-derived [...]
